DIABETES AND ITS COMPLICATIONS: MOLECULAR MECHANISMS AND THERAPEUTIC STRATEGIES

Ergasheva Gulshan Tokhirovna

Authors

Ergasheva Gulshan Tokhirovna Assistant of the Department of Clinical Sciences Asian International University, Bukhara, Uzbekistan

Keywords:

Diabetes

Abstract

Diabetes mellitus is one of the most prevalent metabolic disorders worldwide and represents a major global health challenge.
The disease is characterized by chronic hyperglycemia caused by impaired insulin secretion, insulin resistance, or both. Long‑term hyperglycemia leads to numerous complications affecting different organs and physiological systems. These complications include diabetic nephropathy, retinopathy, neuropathy, and cardiovascular diseases. Recent biomedical research emphasizes the importance of molecular and cellular mechanisms involved in the development of diabetic complications. Chronic inflammation, oxidative stress, endothelial dysfunction, and metabolic imbalance are considered the key factors responsible for tissue damage in diabetic patients. Understanding these mechanisms is essential for developing effective therapeutic strategies and preventing disease progression.

References

American Diabetes Association. (2024). Standards of Medical Care in Diabetes. Diabetes Care.

Brownlee, M. (2005). The pathobiology of diabetic complications: a unifying mechanism. Nature.

DeFronzo, R. A. (2009). From the triumvirate to the ominous octet: a new paradigm for type 2 diabetes mellitus. Diabetes.

Forbes, J. M., & Cooper, M. E. (2013). Mechanisms of diabetic complications. Physiological Reviews.

International Diabetes Federation. (2023). IDF Diabetes Atlas.

Marso, S. P., et al. (2016). Liraglutide and cardiovascular outcomes in type 2 diabetes. New England Journal of Medicine.

Neal, B., et al. (2017). Canagliflozin and cardiovascular and renal events in type 2 diabetes. NEJM.

ERGASHEVA, G. T. (2024). OBESITY AND OVARIAN INSUFFICIENCY. Valeology: International Journal of Medical Anthropology and Bioethics, 2(09), 106-111.

Ergasheva, G. T. (2024). Modern Methods in the Diagnosis of Autoimmune Thyroiditis. American Journal of Bioscience and Clinical Integrity, 1(10), 43-50.

Tokhirovna, E. G. (2024). COEXISTENCE OF CARDIOVASCULAR DISEASES IN PATIENTS WITH TYPE 2 DIABETES. TADQIQOTLAR. UZ, 40(3), 55-62.

Toxirovna, E. G. (2024). DETERMINATION AND STUDY OF GLYCEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH COMORBID DISEASES. TADQIQOTLAR. UZ, 40(3), 71-77.

Toxirovna, E. G. (2024). XOMILADORLIKDA QANDLI DIABET KELTIRIB CHIQARUVCHI XAVF OMILLARINI ERTA ANIQLASH USULLARI. TADQIQOTLAR. UZ, 40(3), 63-70.

Toxirovna, E. G. (2024). QANDLI DIABET 2-TIP VA KOMORBID KASALLIKLARI BO’LGAN BEMORLARDA GLIKEMIK NAZORAT. TADQIQOTLAR. UZ, 40(3), 48-54.

Tokhirovna, E. G. (2024). MECHANISM OF ACTION OF METFORMIN (BIGUANIDE) IN TYPE 2 DIABETES. JOURNAL OF HEALTHCARE AND LIFE-SCIENCE RESEARCH, 3(5), 210-216.

Tokhirovna, E. G. (2024). THE ROLE OF METFORMIN (GLIFORMIN) IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 4(4), 171-177.

Эргашева, Г. Т. (2024). Эффект Применения Бигуанида При Сахарным Диабетом 2 Типа И Covid-19. Research Journal of Trauma and Disability Studies, 3(3), 55-61.

Toxirovna, E. G. (2024). QANDLI DIABET 2 TUR VA YURAK QON TOMIR KASALLIKLARINING BEMOLARDA BIRGALIKDA KECHISHI. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 38(7), 202-209.

Эргашева, Г. Т. (2024). СОСУЩЕСТВОВАНИЕ ДИАБЕТА 2 ТИПА И СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У ПАЦИЕНТОВ. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 38(7), 219-226.